Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.

Breast cancer has become a serious crisis for women worldwide, and this threat is expected to increase in the coming years.

The owner of the Wedding Dress in Portland was set to marry in July but after her stage 4 breast cancer diagnosis in January, ...

Discover the intricate dance between genes, environment, and cancer risk explained by Dr. Ashok Venkitaraman in a ...

But if you inherit mutations of these genes - ‘faulty’ versions that don’t work as they should - this increases your risk of developing cancer. People with mutations in BRCA1 and BRCA2 genes are at ...

This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer ...

Of eight Nolan brothers and sisters, two have died from cancer and three more have now been affected by it. A leading expert ...

Women are being encouraged to seize the opportunity for a potentially life-saving NHS appointment. Anyone can take advantage ...

Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...

First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer. Initiation of trial sites underway for ground ...